Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 4 Week, Parallel-Design, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Treatment of Neuroleptic-Induced Tremor: Clinical and Instrumental Ratings of Outcome.

NCT00533455 is registered in ClinicalTrials.gov with Minneapolis Veterans Affairs Medical Center as lead sponsor.

NCT NCT00533455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00533455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 4 Week, Parallel-Design, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Treatment of Neuroleptic-Induced Tremor: Clinical and Instrumental Ratings of Outcome.
Lead sponsor
Minneapolis Veterans Affairs Medical Center
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2004
Completion date
August 31, 2007
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuroleptic-induced tremor